Current treatments for diabetes are based on the administration of exogenous insulin or insulin analogs, or treatment with agents that stimulate insulin secretion by β-cells, improve insulin sensitivity, promote glucose excretion, or delay carbohydrate digestion. This evidence concerns the gene INS and diabetes mellitus.